Select Search Option
Weill Cornell Medicine
Menu
  • Care
  • Discover
  • Teach
  • Departments
  • WCM
  • About
    • About EIPM
    • Mission
    • Glossary
    • Career Opportunities
    • Support Precision Medicine
    • FAQ
  • Team
    • EIPM Team
    • Partnerships
      • All of Us
      • NYGC
      • cBioPortal
      • EuroPDX
  • News
    • EIPM News
    • Events
  • Care
    • Precision Medicine Care
    • Patient Care
    • Clinicians
    • Clinical Genomic Tests
  • Research
    • EIPM Research
    • Publications
    • Innovation Lab
      • Organoids
      • Non Clinical Assays
        • PreCISE a deep sequencing test for CH and major germline alleles
    • Disease Areas
    • Computational Biomedicine
      • Spatial Computing
        • Oculome
        • Holo Graph
        • DropSeq
        • mrLab
      • AI
        • Precision Medicine Knowledgebase Bot
    • Drug Discovery
    • Molecular Aging Initiative
  • Teach
    • EIPM Education
    • EIPM Internship Program
    • Area of Concentration
    • Tumor Boards
  • Resources
    • Precision Medicine Knowledgebase
    • Preclinical Pharmacy
    • Mass Cytometry
  • Contact
    • Contact Form
Close
  • About
    • About EIPM
    • Mission
    • Glossary
    • Career Opportunities
    • Support Precision Medicine
    • FAQ
  • Team
    • EIPM Team
    • Partnerships
      • All of Us
      • NYGC
      • cBioPortal
      • EuroPDX
  • News
    • EIPM News
    • Events
  • Care
    • Precision Medicine Care
    • Patient Care
    • Clinicians
    • Clinical Genomic Tests
  • Research
    • EIPM Research
    • Publications
    • Innovation Lab
      • Organoids
      • Non Clinical Assays
        • PreCISE a deep sequencing test for CH and major germline alleles
    • Disease Areas
    • Computational Biomedicine
      • Spatial Computing
        • Oculome
        • Holo Graph
        • DropSeq
        • mrLab
      • AI
        • Precision Medicine Knowledgebase Bot
    • Drug Discovery
    • Molecular Aging Initiative
  • Teach
    • EIPM Education
    • EIPM Internship Program
    • Area of Concentration
    • Tumor Boards
  • Resources
    • Precision Medicine Knowledgebase
    • Preclinical Pharmacy
    • Mass Cytometry
  • Contact
    • Contact Form

Tag: NewYork-Presbyterian

HomeNewsTag: NewYork-Presbyterian
EIPM Harnessing Artificial Intelligence Technology for IVF Embryo Selection

EIPM Harnessing Artificial Intelligence Technology for IVF Embryo Selection

December 21, 2022 171 9

An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell...

Read more
Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry

Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry

September 5, 2022 289 2

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their analysis of TNBC tumors from...

Read more
Researchers Identify the Target of Immune Attacks on Liver Cells

Researchers Identify the Target of Immune Attacks on Liver Cells

August 19, 2022 410 6

Researchers Identify the Target of Immune Attacks on Liver Cells in Metabolic Disorders When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that...

Read more
Novel Technique Provides Insights into Lung Pathology in COVID-19

Novel Technique Provides Insights into Lung Pathology in COVID-19

August 4, 2022 343 14

Novel Technique Provides Insights into Lung Pathology in COVID-19 Investigators at Weill Cornell Medicine and NewYork-Presbyterian have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased...

Read more
T Cell Behavior Determines Which Tumors Respond to Treatment

T Cell Behavior Determines Which Tumors Respond to Treatment

May 9, 2022 466 12

Immunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn’t work, and new research may help explain why. When immune cells called T lymphocytes infiltrate malignant tumors, the genetic...

Read more
Novel Technique Provides Insights into Lung Pathology in COVID-19

Novel Technique Provides Insights into Lung Pathology in COVID-19

March 11, 2022 559 8

Novel Technique Provides Insights into Lung Pathology in COVID-19   Investigators at Weill Cornell Medicine and NewYork-Presbyterian have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of...

Read more
Reversing Immune Suppression in Tumors

Reversing Immune Suppression in Tumors

September 20, 2021 796 6

Scientists Find a New Way to Reverse Immune Suppression in Tumors Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine...

Read more
An Ambitious New Plan to Change Medicine

An Ambitious New Plan to Change Medicine

September 15, 2021 918 4

Ready to Launch: Weill Cornell Has an Ambitious New Plan to Change Medicine   Medicine is at a watershed moment: decades of technological advances have revealed unprecedented insights into human biology and how various physiological, genetic...

Read more
Precision Medicine Gives N.J. Woman Second Chance

Precision Medicine Gives N.J. Woman Second Chance

September 8, 2021 846 6

It’s an Absolute Miracle: Battling a Deadly Blood Cancer, a New Jersey Woman Gets a Second Chance — Thanks to Precision Medicine SEPTEMBER 7, 2021 Personalized Care: Dr. Gail Roboz (above right), examines patient Cheryl Bonder this spring as part...

Read more
New Treatment Option for Advanced Bladder Cancer

New Treatment Option for Advanced Bladder Cancer

August 2, 2021 1125 3

New Treatment Option for Advanced Urothelial Cancer Patients Shows Promise in a Phase 2 Clinical Trial   A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2...

Read more
Trial Shows Cell Therapy May Prevent Infections in Patients

Trial Shows Cell Therapy May Prevent Infections in Patients

July 16, 2021 952 6

Phase 2 Trial Shows Cell Therapy May Prevent Infections in Leukemia Patients Treatment with a ready-made preparation of human immune cells helps prevent infections in people whose immune systems are temporarily weakened by leukemia treatment...

Read more
Breast Cancer Risk in African Americans Tied to Genetic Variations

Breast Cancer Risk in African Americans Tied to Genetic Variations

June 14, 2021 1035 6

Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian...

Read more
12
Our Location
Caryl and Israel Englander
Institute for Precision Medicine
Contact Us
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
413 E 69th Street
Belfer Research Building
New York, NY 10021
  • About +
  • Patients +
  • Clinicians +
  • News +
  • Innovation Lab +
  • Education +
  • Contact +
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.
Weill Cornell Medicine NewYork - Presbyterian
© Weill Cornell Medicine.
  • Privacy & Legal
  • Careers
  • Giving
  • Directory
Forgot password?
You can login using your social profile
Problem with login?